Represented Maxim Group LLC as lead dealer-manager and National Securities Corporation as co-dealer-manager in a $13.8 million rights offering for Opexa Therapeutics, Inc., a NASDAQ-listed biotechnology company.
-
副主席兼纽约办公室管理合伙人;资本市场及公司业务部联席主席;亚洲业务部主席”; 纽约,北京
-
合伙人
-
资深顾问律师